SCHEMBL7008328

SCHEMBL7008328

CC(Cc1ccc([N+](=O)[O-])cc1)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.55
MEN1 O00255 2/20 0.55
NPC1 O15118 1/20 0.52
TP53 P04637 1/20 0.52
RAB9A P51151 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
CYP1A2 P05177 1/20 0.50
CYP2C19 P33261 1/20 0.50
CRHBP P24387 1/20 0.50
CRHR2 Q13324 1/20 0.50
PTPRF P10586 1/20 0.49
PTPN2 P17706 1/20 0.49
PTPN1 P18031 1/20 0.49
PTPN11 Q06124 1/20 0.49
ALDH1A1 P00352 4/20 0.48
LMNA P02545 1/20 0.48
KCNJ1 P48048 2/20 0.48
KCNH2 Q12809 2/20 0.48
MAPT P10636 2/20 0.47
OPRM1 P35372 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11262646 0.84 CYP1A2 (0.54) KMT2AMEN1NPC1TP53RAB9A
SCHEMBL11024329 0.84 ESR1 (0.69) KMT2AMEN1NPC1TP53RAB9A
SCHEMBL4437809 0.84 POLB (0.58) KMT2AMEN1NPC1TP53RAB9A
SCHEMBL5261202 0.83 KCNJ1 (0.45) KMT2AMEN1NPC1TP53RAB9A
SCHEMBL9069704 0.82 ESR1 (0.61)
Ammonia Solution, Strong SCHEMBL8867125 0.81 CYP2D6 (0.52) KMT2AMEN1SMN1; SMN2CYP1A2CYP2C19
Ammonia Solution, Strong SCHEMBL8975868 0.81 SMN1; SMN2 (0.53) KMT2AMEN1NPC1TP53RAB9A
Iodide SCHEMBL5262196 0.81 KCNJ1 (0.44) KMT2AMEN1NPC1TP53RAB9A
SCHEMBL7118574 0.80 CYP1A2 (0.50) KMT2AMEN1NPC1TP53RAB9A
SCHEMBL27864585 0.80 ALDH1A1 (0.62) KMT2AMEN1CYP1A2CYP2C19CRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1267906-A1 LACTAMS AS INHIBITORS OF A-BETA PROTEIN PRODUCTION Bristol-Myers Squibb Pharma Company (US) 2003-01-02 EP claimed
WO-2001072324-A1 LACTAMS AS INHIBITORS OF A-BETA PROTEIN PRODUCTION BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-10-04 WO claimed